Enter assignee name

% Expired Patents = 26.7

EPO Patents = 8

Forward Citations = 178

Loading Chart...

3 inventors (with patents filed for the assignee):

Viktor Veniaminovich Tets (15 out of 45 patents)

Georgy Viktorovich Tets (15 out of 43 patents)

Dmitry Dmitrievich Genkin (15 out of 21 patents)

4. Georgy Victorovich Tets (0 patent)

5. Victor Veniaminovich Tets (0 patent)

15 patents: Sort by Forward Citations

1. 11905522 - Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity (2024-02-20),

2. 11701410 - Extracellular DNA as a therapeutic target in neurodegeneration (2023-07-18),

3. 10617743 - Method to improve safety and efficacy of anti-cancer therapy (2020-04-14),

4. 9845461 - Method for treating oncological diseases (2017-12-19),

5. 9770492 - Method for treating systemic DNA mutation disease (2017-09-26),

6. 9463223 - Method for monitoring development of somatic mosaicism (2016-10-11),

7. 9248166 - Method for treating oncological diseases (2016-02-02),

8. 9072733 - Method for treating systemic bacterial, fungal and protozoan infection (2015-07-07),

9. 8916151 - Method for treating a reduction of fertility (2014-12-23),

10. 8871200 - Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method (2014-10-28),

11. 8796004 - Method for treating systemic DNA mutation disease (2014-08-05),

12. 8710012 - Method for treating oncological diseases (2014-04-29),

13. 8535663 - Method for treating delayed-type hypersensitivity (2013-09-17),

14. 8431123 - Method for treating systemic bacterial, fungal and protozoan infection (2013-04-30),

15. 8388951 - Method for treating systemic DNA mutation disease (2013-03-05),

Cls Therapeutics Limited is a biopharmaceutical company based in Guernsey, specializing in the development of innovative therapies for various medical conditions. The organization focuses on advancing drug discovery and delivery technologies, aiming to improve patient outcomes through targeted treatments. With a commitment to research excellence, Cls Therapeutics operates within the broader healthcare landscape, contributing to advancements in therapeutic solutions and enhancing the quality of life for patients globally.

Profile summary based on public USPTO records.